Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Ligand | BDBM347982 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Enzymatic Assay | ||
IC50 | <100±n/a nM | ||
Citation | Jorand-Lebrun, C; Jones, R; Won, AC; Nguyen, N; Johnson, TL; Deselm, LC; Panda, K Heteroaryl compounds as IRAK inhibitors and uses thereof US Patent US9790221 Publication Date 10/17/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Interleukin-1 receptor-associated kinase 1 [194-712] | |||
Name: | Interleukin-1 receptor-associated kinase 1 [194-712] | ||
Synonyms: | IRAK | IRAK1 | IRAK1_HUMAN | Interleukin-1 receptor-associated kinase 1 (IRAK1) | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 55943.99 | ||
Organism: | Homo sapiens (Human) | ||
Description: | aa 194-712 | ||
Residue: | 519 | ||
Sequence: |
| ||
BDBM347982 | |||
n/a | |||
Name | BDBM347982 | ||
Synonyms: | US9790221, Compound 188 | ||
Type | Small organic molecule | ||
Emp. Form. | C23H26N8 | ||
Mol. Mass. | 414.5061 | ||
SMILES | Cn1cc(cn1)-c1cccc(c1)-c1ncc(-c2cnn(C)c2)c(NC2CC(CN)C2)n1 |(2.91,5.84,;1.43,6.23,;.52,4.99,;-.94,5.46,;-.94,7,;.52,7.48,;-2.28,4.69,;-3.61,5.46,;-4.94,4.69,;-4.94,3.15,;-3.61,2.38,;-2.28,3.15,;-3.61,.84,;-4.94,.07,;-4.94,-1.47,;-3.61,-2.24,;-3.61,-3.78,;-4.86,-4.68,;-4.38,-6.15,;-2.84,-6.15,;-2.07,-7.48,;-2.36,-4.68,;-2.28,-1.47,;-.94,-2.24,;.39,-1.47,;1.88,-1.86,;2.28,-.38,;3.61,.39,;4.94,-.38,;.79,.02,;-2.28,.07,)| | ||
Structure |